Joan Bartra
University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joan Bartra.
Clinical & Experimental Allergy | 2012
Mariona Pascal; Rosa Muñoz-Cano; Z. Reina; A. Palacín; Ramón Vilella; César Picado; Manel Juan; Jaime Sánchez-López; Maria Rueda; G. Salcedo; Antonio Valero; Jordi Yagüe; Joan Bartra
Multiple plant‐food sensitizations with a complex pattern of clinical manifestations are a common feature of lipid transfer protein (LTP)‐allergic patients. Component‐resolved diagnosis permits the diagnosis of the allergen sensitization profile.
Pediatric Allergy and Immunology | 2011
Jáuregui I; Dávila I; Joaquín Sastre; Joan Bartra; Alfonso del Cuvillo; Marta Ferrer; Montoro J; Joaquim Mullol; Xavier Molina; Antonio Valero
To cite this article: Jáuregui I, Dávila I, Sastre J, Bartra J, del Cuvillo A, Ferrer M, Montoro J, Mullol J, Molina X, Valero A. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study. Pediatr Allergy Immunol 2011; 22: 388–392.
PLOS ONE | 2012
Arantxa Palacín; Luis Rivas; Cristina Gómez-Casado; Jacobo Aguirre; Leticia Tordesillas; Joan Bartra; Carlos A. Blanco; Teresa Carrillo; Javier Cuesta-Herranz; José A. Cumplido Bonny; Enrique Flores; Mar G. García-Alvarez-Eire; Ignacio García-Nuñez; Francisco J. Fernández; Pedro M. Gamboa; Rosa Muñoz; Rosa Sánchez-Monge; María V. Torres; Susana Varela Losada; Mayte Villalba; Francisco M. Vega; Victor Parro; Miguel Blanca; Gabriel Salcedo; Araceli Díaz-Perales
Cross-reactivity of plant foods is an important phenomenon in allergy, with geographical variations with respect to the number and prevalence of the allergens involved in this process, whose complexity requires detailed studies. We have addressed the role of thaumatin-like proteins (TLPs) in cross-reactivity between fruit and pollen allergies. A representative panel of 16 purified TLPs was printed onto an allergen microarray. The proteins selected belonged to the sources most frequently associated with peach allergy in representative regions of Spain. Sera from two groups of well characterized patients, one with allergy to Rosaceae fruit (FAG) and another against pollens but tolerant to food-plant allergens (PAG), were obtained from seven geographical areas with different environmental pollen profiles. Cross-reactivity between members of this family was demonstrated by inhibition assays. Only 6 out of 16 purified TLPs showed noticeable allergenic activity in the studied populations. Pru p 2.0201, the peach TLP (41%), chestnut TLP (24%) and plane pollen TLP (22%) proved to be allergens of probable relevance to fruit allergy, being mainly associated with pollen sensitization, and strongly linked to specific geographical areas such as Barcelona, Bilbao, the Canary Islands and Madrid. The patients exhibited >50% positive response to Pru p 2.0201 and to chestnut TLP in these specific areas. Therefore, their recognition patterns were associated with the geographical area, suggesting a role for pollen in the sensitization of these allergens. Finally, the co-sensitizations of patients considering pairs of TLP allergens were analyzed by using the co-sensitization graph associated with an allergen microarray immunoassay. Our data indicate that TLPs are significant allergens in plant food allergy and should be considered when diagnosing and treating pollen-food allergy.
Allergy | 2009
Jose Maria Guilemany; J. Angrill; Isam Alobid; Silvia Centellas; Laura Pujols; Joan Bartra; Manuel Bernal-Sprekelsen; Antonio Valero; César Picado; J. Mullol
Background: Although various relationships between the lower and upper airways have been found, the association of bronchiectasis with chronic rhinosinusitis and nasal polyps has not been thoroughly evaluated. This study was undertaken to examine the association of idiopathic and postinfective bronchiectasis with chronic rhinosinusitis and nasal polyposis.
Expert Opinion on Biological Therapy | 2013
Moises Labrador-Horrillo; Antonio Valero; Manuel Velasco; Jáuregui I; Joaquín Sastre; Joan Bartra; Juan Francisco Silvestre; Javier Ortiz de Frutos; Ana Giménez-Arnau; Marta Ferrer
Objective: To collect data on the efficacy and safety of omalizumab in 110 patients from 9 Spanish hospitals suffering from chronic spontaneous urticaria (CSU) refractory to conventional treatment. Methods: A retrospective, descriptive analysis was performed, showing the data of 110 patients suffering from refractory CSU who received omalizumab as an off-label treatment in 9 Spanish hospitals from October 2009 to September 2012. Results: Ninety (81.8%) patients exhibited a complete or significant response, 12 (10.9%) had partial response, and 8 (7.2%) showed no response. Sixty-six (60%) patients were able to stop all concomitant medications, remaining asymptomatic treated with omalizumab alone. No serious adverse events were reported. Conclusions: Omalizumab shows excellent efficacy and safety profile in a large series of CSU patients in real-life practice. This drug will contribute to settle the debt with CSU patients contributing to restore their quality of life.
Allergy | 2012
Montoro J; A. Del Cuvillo; Joaquim Mullol; X. Molina; Joan Bartra; Dávila I; Marta Ferrer; Jáuregui I; Joaquín Sastre; Antonio Valero
A modified allergic rhinitis and its impact on asthma (ARIA) (m‐ARIA) criterion to classify the severity of allergic rhinitis (AR) has recently been validated in both treated and untreated adult patients; however, such information in children is lacking. The aim of this study was to validate this m‐ARIA severity criterion, which allows for discrimination between moderate and severe AR, in a large pediatric patient sample population.
Rhinology | 2010
del Cuvillo A; Montoro J; Joan Bartra; Antonio Valero; Marta Ferrer; Jáuregui I; Dávila I; Joaquín Sastre; Joaquim Mullol
INTRODUCTION Allergic rhinitis (AR) is an increasingly prevalent worldwide disease, which has an important impact on quality of life and generates high social and health care costs. The ARIA classification, that considers both the duration and severity of AR, seems more appropriate than previous classifications of AR, but few studies exist on the validation of the severity criteria proposed by the ARIA classification. OBJECTIVES To assess the ARIA duration and severity classification of AR in a large sample population of patients, by investigating whether different degrees of severity correlate with differences in symptom score, quality of life or the patients self evaluation of impairment. This study also assesses the relationship between AR severity and co morbidities. MATERIAL AND METHODS An observational, cross-sectional, multicentre study conducted in Spain. AR was classified based on the ARIA criteria, and compared to the classical classification based on allergen exposure. Rhinitis was evaluated by the Total 4-Symptom Score (T4SS) scale, quality of life was measured using the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), and disease severity through a Visual Analogue Scale (VAS, 0-100 mm). Comorbidities were evaluated based both on the duration and severity of the symptoms of rhinitis. RESULTS AR patients, (n = 3,529; mean age 37.5 +/= 13.4 years; 52.3% women) were included in the study. AR patients were classified as intermittent (51.5%) and persistent (48.5%) based on the ARIA classification, and as seasonal (61.2%), perennial (35.1%), and occupational (3.7%) based on the allergen exposure classification. Significantly higher T4SS, RQLQ and VAS scores were obtained in moderate/severe compared to mild AR. The incidence of asthma was significantly higher in patients with persistent and moderate/severe AR compared to intermittent and mild AR. Asthma was the only co morbidity to reach statistical significance. CONCLUSION ARIA classification of severity reflects two different statuses of AR in terms of symptoms and quality of life. Asthma was the only concomitant pathology in which incidence was related to ARIA categories in terms of duration or severity.
International Archives of Allergy and Immunology | 2010
Arantxa Palacín; Joan Bartra; Rosa Muñoz; Araceli Díaz-Perales; Antonio Valero; Gabriel Salcedo
Background: Food allergy to wheat-derived foodstuffs is on the rise. Tri a 14, a wheat flour lipid transfer protein (LTP) allergen, has been described as a major allergen associated with baker’s asthma and wheat food allergy. Cross-reactivity among LTP allergens leads to the so-called ‘LTP syndrome’. Methods: Eight adult patients showing anaphylaxis after ingestion of wheat-derived foodstuffs were selected. A homemade wheat extract, purified natural (n) and recombinant (r) Tri a 14, and peach fruit and Artemisia pollen LTP allergens Pru p 3 and Art v 3 were subjected to skin prick test, specific IgE determination (ELISA) and IgE immunodetection assays. Results: All tests were positive in the 8 selected patients with the homemade extract. Positive skin prick test responses to nTri a 14, Pru p 3 and Art v 3 were found in 5/8, 6/8 and 4/4 patients, respectively. Specific IgE determined by ELISA assays was detected in 6 to nTri a 14 and rTri a 14, in 4 to Pru p 3 and in 3 to Art v 3 out of 8 individual sera tested, whereas all these sera showed IgE binding to nTri a 14 and Pru p 3 in immunodetection after SDS-PAGE separation. Conclusions: Tri a 14 seems to be a relevant allergen in patients with anaphylaxis after ingestion of wheat flour foodstuffs, according to in vitro and in vivo results. Clinical history of the analyzed patients, together with sensitization to peach Pru p 3 and Artemisia pollen Art v 3, suggests that 6 of them suffer from LTP syndrome.
Clinical & Experimental Allergy | 2007
C. H. Larramendi; A. Ferrer; A. J. Huertas; J. L. García-Abujeta; C. Andreu; R. Tella; M. T. Cerdà; Joan Bartra; J. R. Lavín; J. A. Pagán; M. A. López-Matas; Enrique Fernández-Caldas; J. Carnés
Background Tomatoes (Lycopersicon esculentum) are consumed world‐wide. The prevalence of sensitization to tomatoes remains unknown.
Allergy | 2008
C. Serrano; Mar Guilarte; R. Tella; G. Dalmau; Joan Bartra; P. Gaig; M. Cerdà; Victoria Cardona; Antonio Valero
Background: Hereditary angio‐oedema (HAE) is a rare condition in which there is a deficiency in the quantity or activity of C1 inhibitor (C1INH). Recently, an additional type of HAE with no alterations in the levels or the function of C1INH has been reported. It is defined as HAE with normal C1INH, and named type III HAE or oestrogen‐dependent HAE. The aim of this study is to describe the clinical and laboratory findings of six new cases of type III HAE and to review the literature about this disease.